These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 30501643)

  • 1. Integrated proteotranscriptomics of breast cancer reveals globally increased protein-mRNA concordance associated with subtypes and survival.
    Tang W; Zhou M; Dorsey TH; Prieto DA; Wang XW; Ruppin E; Veenstra TD; Ambs S
    Genome Med; 2018 Dec; 10(1):94. PubMed ID: 30501643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis of breast tumors confirms the mRNA intrinsic molecular subtypes using different classifiers: a large-scale analysis of fresh frozen tissue samples.
    Waldemarson S; Kurbasic E; Krogh M; Cifani P; Berggård T; Borg Å; James P
    Breast Cancer Res; 2016 Jun; 18(1):69. PubMed ID: 27357824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteome Profiling Outperforms Transcriptome Profiling for Coexpression Based Gene Function Prediction.
    Wang J; Ma Z; Carr SA; Mertins P; Zhang H; Zhang Z; Chan DW; Ellis MJ; Townsend RR; Smith RD; McDermott JE; Chen X; Paulovich AG; Boja ES; Mesri M; Kinsinger CR; Rodriguez H; Rodland KD; Liebler DC; Zhang B
    Mol Cell Proteomics; 2017 Jan; 16(1):121-134. PubMed ID: 27836980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptomic and Protein Expression Analysis Reveals Clinicopathological Significance of Bloom Syndrome Helicase (BLM) in Breast Cancer.
    Arora A; Abdel-Fatah TM; Agarwal D; Doherty R; Moseley PM; Aleskandarany MA; Green AR; Ball G; Alshareeda AT; Rakha EA; Chan SY; Ellis IO; Madhusudan S
    Mol Cancer Ther; 2015 Apr; 14(4):1057-65. PubMed ID: 25673821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide analysis of alternative transcripts in human breast cancer.
    Wen J; Toomer KH; Chen Z; Cai X
    Breast Cancer Res Treat; 2015 Jun; 151(2):295-307. PubMed ID: 25913416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity.
    Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM
    Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Proteomics of Breast Cancer Reveals a Novel Layer of Breast Cancer Classification.
    Yanovich G; Agmon H; Harel M; Sonnenblick A; Peretz T; Geiger T
    Cancer Res; 2018 Oct; 78(20):6001-6010. PubMed ID: 30154156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semaphorin-plexin signalling genes associated with human breast tumourigenesis.
    Gabrovska PN; Smith RA; Tiang T; Weinstein SR; Haupt LM; Griffiths LR
    Gene; 2011 Dec; 489(2):63-9. PubMed ID: 21925246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.
    Hachim IY; Shams A; Lebrun JJ; Ali S
    Hum Pathol; 2016 Jul; 53():142-52. PubMed ID: 26980025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
    Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
    Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coupling proteomics and transcriptomics in the quest of subtype-specific proteins in breast cancer.
    Pavlou MP; Dimitromanolakis A; Diamandis EP
    Proteomics; 2013 Apr; 13(7):1083-95. PubMed ID: 23386393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
    Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
    J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteome profiling of breast cancer biopsies reveals a wound healing signature of cancer-associated fibroblasts.
    Groessl M; Slany A; Bileck A; Gloessmann K; Kreutz D; Jaeger W; Pfeiler G; Gerner C
    J Proteome Res; 2014 Nov; 13(11):4773-82. PubMed ID: 25238572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protein profiling of human breast tumor cells identifies novel biomarkers associated with molecular subtypes.
    Gonçalves A; Charafe-Jauffret E; Bertucci F; Audebert S; Toiron Y; Esterni B; Monville F; Tarpin C; Jacquemier J; Houvenaeghel G; Chabannon C; Extra JM; Viens P; Borg JP; Birnbaum D
    Mol Cell Proteomics; 2008 Aug; 7(8):1420-33. PubMed ID: 18426791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Label-free proteomic analysis of breast cancer molecular subtypes.
    Panis C; Pizzatti L; Herrera AC; Corrêa S; Binato R; Abdelhay E
    J Proteome Res; 2014 Nov; 13(11):4752-72. PubMed ID: 25221861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multipronged quantitative proteomics reveals serum proteome alterations in breast cancer intrinsic subtypes.
    Gajbhiye A; Dabhi R; Taunk K; Jagadeeshaprasad MG; RoyChoudhury S; Mane A; Bayatigeri S; Chaudhury K; Santra MK; Rapole S
    J Proteomics; 2017 Jun; 163():1-13. PubMed ID: 28495502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomic maps of breast cancer subtypes.
    Tyanova S; Albrechtsen R; Kronqvist P; Cox J; Mann M; Geiger T
    Nat Commun; 2016 Jan; 7():10259. PubMed ID: 26725330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective personalized therapy for breast cancer based on predictions of cell signaling pathway activation from gene expression analysis.
    Jhan JR; Andrechek ER
    Oncogene; 2017 Jun; 36(25):3553-3561. PubMed ID: 28135251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated quantitative proteomic and transcriptomic analysis of lung tumor and control tissue: a lung cancer showcase.
    Tenzer S; Leidinger P; Backes C; Huwer H; Hildebrandt A; Lenhof HP; Wesse T; Franke A; Meese E; Keller A
    Oncotarget; 2016 Mar; 7(12):14857-70. PubMed ID: 26930711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ proteomic analysis of human breast cancer epithelial cells using laser capture microdissection: annotation by protein set enrichment analysis and gene ontology.
    Cha S; Imielinski MB; Rejtar T; Richardson EA; Thakur D; Sgroi DC; Karger BL
    Mol Cell Proteomics; 2010 Nov; 9(11):2529-44. PubMed ID: 20739354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.